These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17523726)

  • 1. Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencing vasomotor rhinitis.
    Davis GA; Rudy AC; Archer SM; Wermeling DP; McNamara PJ
    Clin Drug Investig; 2004; 24(11):633-9. PubMed ID: 17523726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluticasone propionate nasal spray on bioavailability of intranasal hydromorphone hydrochloride in patients with allergic rhinitis.
    Davis GA; Rudy AC; Archer SM; Wermeling DP; McNamara PJ
    Pharmacotherapy; 2004 Jan; 24(1):26-32. PubMed ID: 14740785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers.
    Coda BA; Rudy AC; Archer SM; Wermeling DP
    Anesth Analg; 2003 Jul; 97(1):117-23, table of contents. PubMed ID: 12818953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.
    Shyu WC; Pittman KA; Robinson DS; Barbhaiya RH
    Eur J Clin Pharmacol; 1993; 45(6):559-62. PubMed ID: 8157043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multiple-dose phase I study of intranasal hydromorphone hydrochloride in healthy volunteers.
    Rudy AC; Coda BA; Archer SM; Wermeling DP
    Anesth Analg; 2004 Nov; 99(5):1379-1386. PubMed ID: 15502034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration.
    Wermeling DP; Miller JL; Archer SM; Manaligod JM; Rudy AC
    J Clin Pharmacol; 2001 Nov; 41(11):1225-31. PubMed ID: 11697755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration in guinea pigs (
    Ambros B; Knych HK; Sadar MJ
    Am J Vet Res; 2020 Apr; 81(4):361-366. PubMed ID: 32228262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioavailability of hydromorphone: effect of various routes of administration.
    Chang SF; Moore L; Chien YW
    Pharm Res; 1988 Nov; 5(11):718-21. PubMed ID: 2470073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
    Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
    Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human pharmacokinetics of dihydroergotamine administered by nasal spray.
    Humbert H; Cabiac MD; Dubray C; Lavène D
    Clin Pharmacol Ther; 1996 Sep; 60(3):265-75. PubMed ID: 8841149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
    Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
    Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of hydrorphone hydrochloride after intravenous and subcutaneous administration in ferrets (Mustela putorius furo).
    Hech B; Knych H; Desprez I; Weiner D; Ambros B
    Vet Anaesth Analg; 2024; 51(2):152-159. PubMed ID: 38158281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic profile of beclomethasone dipropionate hydrofluoroalkane after intranasal administration versus oral inhalation in healthy subjects: results of a single-dose, randomized, open-label, 3-period crossover study.
    Ratner PH; Melchior A; Dunbar SA; Tantry SK; Dorinsky PM
    Clin Ther; 2012 Jun; 34(6):1422-31. PubMed ID: 22621776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food.
    Sathyan G; Xu E; Thipphawong J; Gupta SK
    BMC Clin Pharmacol; 2007 Feb; 7():2. PubMed ID: 17270055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of concentrated naloxone nasal spray over first 30 minutes post-dosing: analysis of suitability for opioid overdose reversal.
    Mundin G; McDonald R; Smith K; Harris S; Strang J
    Addiction; 2017 Sep; 112(9):1647-1652. PubMed ID: 28430384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration: a pilot pharmacokinetic study.
    Miller JL; Ashford JW; Archer SM; Rudy AC; Wermeling DP
    Pharmacotherapy; 2008 Jul; 28(7):875-82. PubMed ID: 18576902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs.
    van Hoogdalem E; de Boer AG; Breimer DD
    Clin Pharmacokinet; 1991 Jul; 21(1):11-26. PubMed ID: 1717195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults.
    Henney HR; Sperling MR; Rabinowicz AL; Bream G; Carrazana EJ
    Epilepsy Res; 2014 Sep; 108(7):1204-11. PubMed ID: 24934774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.
    Foster D; Upton R; Christrup L; Popper L
    Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers.
    Cass LM; Efthymiopoulos C; Bye A
    Clin Pharmacokinet; 1999; 36 Suppl 1():1-11. PubMed ID: 10429835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.